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Alzheimer s´ Disease and Age-related Macular Degeneration could 
simultaneously be treated or prevented with a single therapeutic 
intervention
Alzheimer ´s diseases becomes the most common type of de-
mentia in the world. There is more of 5.4 million AD patients in 
America, more than 6 million patients in China, and 35.6 million 
patients worldwide.  AD and other dementias worldwide will in-
crease to 67.5 million by 2030 and 115.4 million by 2050. In the 
aging population, two of the most common neurodegenerative 
diseases, AD and AMD, could simultaneously treated or prevent-
ed with single therapeutic intervention. 
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Background: 
Age related macular degeneration (AMD) is the 
leading cause of visual impairment in elderly 
persons in industrialized countries [1]. 
Alzheimer s´ disease and AMD have long been 
hypothesized to share a common pathogenesis 
based on several lines of evidence. Both 
conditions have similar histopathological 
changes [2], as drusen accumulations, 
containing β-amyloid, lipid, and other 
neurodegeneration waste products. Supposedly 
these deposits may lead to subsequent retinal 
pigment epithelial changes, photoreceptor 
malfunctions, neovascularization, and 
eventually atrophy. 
In Alzheimer s´ disease, an accumulation of 
extracellular β-amyloid, axonal and dendritic 
waste products from dystrophic neurons has 
been documented. These deposits form senile 
plaques and neurofibrillary tangles in the cortex 
and hippocampus of the brain that lead to 
neuronal malfunction and cell death.  
AMD and AD share similar vascular risk factors 
[3], such as hypertension, and cigarette smoking. 
Both AMD and AD have been linked to an 
increased risk of stroke [4].  
The similarities shown in the various studies 
have led to the belief that in the aging population, 
two of the most common neurodegenerative 
diseases, AD and AMD, could simultaneously be 
treated or prevented with a single intervention 
[5]. 
Introduction: 
In biology and thereby medicine, there are two 
widely and deep-rooted dogma: First) Glucose 
has a double function as universal precursor of 
any organic matter in the body, and second) 
melanin is a simple sunscreen that tends to 
disappear with civilization. It is alleged that 
people in high latitudes in Europe and east Asia 
independently evolved lighter skin to produce 
vitamin D more efficiently with less sunlight [6]. 
However, the results of our study shattered both 
dogmas.    
In 1990, we began a descriptive, observational 
study about the three main causes of blindness 
(AMD, Diabetic retinopathy, and glaucoma) and 
its possible correlation with anatomical 
variations of the minute vessels that pass 
through the optic nerve. Due to the optic nerve 
in humans is so small, 1200 microns, it was 
necessary to use significant enlargement of 
images obtained from retina s´ patient to get 
enough definition of anatomic details of these 
blood vessels; magnification was achieved 
through optical and digital means. Photographic 
files of 6000 patients were included along 12 
years of the study.  
A few weeks after the study started, we noticed 
the constant presence of melanin in the vicinity 
of the optical disc (figure 1), so we decided to 
include it as a variable in study, after the blood 
vessels of the optic nerve, which until then was 
the main variable in study. 
 
Figure 1) Image of the optic nerve of the left eye, the anatomical details of the blood vessels 
of the optic nerve are appreciated, and in turn, a dark edge can be detected in the meridian 
of 2 to 5 that corresponds to the melanin (arrows). 
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Our study leads us to find three axioms: 
Melanin is present nearby optic nerve of all 
human beings. It is an ancient observation, 
since Helmholtz Ophthalmoscope invention 
(1851), however, the analysis of retina 
photographs raises in our team the awareness 
of the ever presence of melanin around the optic 
nerve in humans. The traditional explanation 
about these significant phenomena is roughly as 
embryonic remnants, or sometimes are sequels 
of local or systemic inflammatory processes in 
the past, and so on. However, nature just insist 
in important things, thereby we tried to find some 
other explanation. 
As our research progressed, we began to detect 
that the blood vessels seemed to respond to the 
presence of melanin, and as the presence of 
melanin was constant in all the patients we 
examined, also the substantive antiangiogenic 
effect of melanin was remarkably persistent. 
Finally, we built a second axiom: 
With a greater amount of melanin there will 
be a lower number and caliber of blood 
vessels and vice versa. 
Now, we had to explain the mechanism. By one 
side, melanin is an amorphous substance, 
therefore it has not something that could be 
considered as factory of peptide factors; and 
neither has something that could resemble as a 
receptor of some type. Thereby, the cross-talk 
between endothelial cells of blood vessels and 
melanin cannot be through peptide factors or 
something similar that could be produced by 
endothelial cells, because melanin does not 
have some type of receptor biologically 
accepted or at least described. 
Our partial conclusion was that blood vessels 
obey melanin presence through some type of 
unknown communication which is remarkably 
efficient. Our efforts to find the answer led us to 
detect a third axiom: 
A higher amount of melanin means a higher 
level of oxygen in the tissues and vice versa. 
This finding represented the long-sought answer 
because the best anti-angiogenic agent is 
known are the elevated levels of oxygen in the 
tissues.  
The doubt was resolved, but what was next was 
trying to find where so much oxygen came from, 
because in our working conditions the difference 
reached 34%. We analyzed the metabolic 
processes described in the literature concerning 
the tissue in question, but we could not find any 
process or molecule that could donate such a 
quantity of oxygen so consistently. 
So, we began to examine the molecule with 
greater presence in the eye and that is the water, 
since more than 95% of the eyeball is constituted 
by it, at least in number of molecules. 
It seemed feasible that oxygen would come from 
the water of the Vitreous body, but the water 
does not release the oxygen easily, it is 
necessary some mechanism to remove it from 
there when it is dissolved in enough amount, or 
the next possibility was that melanin could 
dissociate the molecule of the water.  
And the conditions were given. The eye has 40% 
more melanin than the skin, its water content 
exceeds 90%, and the amount of light is 
adequate, and even concentrated by the natural 
lenses that are the crystalline and the cornea. A 
few experiments in the laboratory were enough 
to demonstrate the hitherto unknown intrinsic 
property of melanin to dissociate the water 
molecule [7].  
Once we could take the biological event to the 
test tube,  the results left us astonished because 
the melanin is not only able to dissociate the 
molecule of the water, but it is also capable of 
reforming it (Figure 2). 
2H2O  → 2H2 + O2  → 2H2O + 4e
-   
Figure 2) Melanin absorbs visible and invisible 
light and dissipate the absorbed energy 
dissociating the water molecule. However, 
melanin can support the opposite reaction: the 
back-bonding of Hydrogen and oxygen; and for 
each two molecules of re-formed water 4 high 
energy electrons (4e-) are generated.  
The conclusions of that study were surprising, 
melanin has an unsuspected bio-energetic 
biological role. Glucose is the universal 
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precursor of any organic matter but cannot 
provide the energy that its own metabolism 
requires [8].   
So, the dogma that our body gets energy by 
combining glucose with oxygen gradually 
(graduated combustion?) was difficult to accept 
because oxygen is toxic to any concentration, 
and on the other hand the sacrosanct role of 
glucose as a source of energy is broken into a 
thousand pieces.  
The role of energy in the functioning of the 
human body 
It is widely accepted that energy metabolism 
plays a role in health and aging as well as 
disease. Energy must be available for the work 
of synthesizing new cellular material, 
maintaining membranes and organelles, and to 
fuel movement and active transport.  
In the 19th century researchers first released that 
metabolism can be viewed as a highly complex 
network of connected biochemical reactions. 
Enzymes catalyze these reactions, this is, they 
enable them and modulate the rate at which they 
take place. However, an enzyme does not make 
possible an impossible chemical reaction. 
Since the first scientific article on a metabolic 
process in the 17th century nearly six million 
articles on metabolism have been published. 
And every day articles that seem to add one 
more piece of the puzzle about the mechanisms 
of metabolic processes in humans and many 
other organisms continue to be published.  To 
understand the metabolism, we need to know 
how the reactions and the enzymes catalyzing 
them fit together and act as a whole.  
The idea that energy and mass come from the 
same source (food); it is very old, and that 
glucose specifically is the main molecule that 
provides at the same time to the organism with 
carbon chains and energy began to emerge in 
the 17th century. However, of the about 70000 
chemical reactions described in the literature 
that have been published trying to build a logical 
sequence that explains the apparent double 
function of glucose, just in 199 there is 
consensus and, in the rest, (≈6801) is 
controversial [9].  
The importance of metabolism (continuous 
change) is such that several of the most 
prevalent diseases in modern society, including 
diabetes, cardiovascular diseases and obesity 
involve disruptions of metabolic processes. 
Even in cancer, metabolism also plays an 
important role, as a tumor requires energy to 
grow [10].  
It is to attract the attention that no one uses in 
the clinical practice the ATP to raise the levels of 
energy of the patients. And the reason is that in 
experimental animals as well as in some very 
small clinical trials the results have been 
disastrous [11]. What was to be expected 
because if glucose was a source of energy the 
diabetics patients would fly. 
Energy in the clinical practice 
Roughly speaking, 40% of the energy the body 
gets from glucose is used to boost the necessary 
chemical reactions, and 60% dissipates and 
maintains the proper body temperature. 
Therefore, the measurement of body 
temperature gives us an approximate idea of the 
energy state of the organism, but not for the 
above reasons. Temperature measurement is a 
coarse, inaccurate method.  
IF ATP were the universal Energy exchange 
currency then the determination of the 
concentration of the energy carrier molecule, 
adenosine-5 -´triphosphate (ATP) supposedly 
may assess the energy state in cells but given 
the complexity of the procedure is not of practical 
use in the clinic, besides that the levels of energy 
change constantly.  It is argued that cellular ATP 
is an important element of cell death by 
apoptosis or necrosis [12]. Thereby, it is thought 
that a decreased cellular ATP level is 
characteristic for cell death, but there is no 
systematic investigation whether the decrease is 
the cause or consequence of cell death, or 
simply a detectable part of an extraordinarily 
complex biological system.  
Because in everyday clinical practice we only 
have a limited number of paraclinical studies, for 
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practical purposes mitochondria and ATP are 
supposed to be the basis for the exchange of 
energy in the eukaryotic cell, and if blood 
glucose levels are within adequate limits, it is 
assumed that mitochondria and ATP will also be. 
And the clinician automatically focuses on 
detectable alterations by physical examination 
and para-clinical test.  
However, the biology of eukaryotic cell and our 
organism can be divided in mass (everything 
that has a place in the space) and energy 
(everything that produce a change). The current 
medicine is mainly based on the examination of 
the mass, since the energy is difficult to evaluate 
and it is generally accepted that if the glucose is 
well, then the levels of energy will certainly be 
the appropriate ones.  
 But neither mitochondria nor ATP are energy 
sources, because the molecular hydrogen (H2) 
derived from the dissociation of the water 
molecule and the high energy electrons (e-) that 
are generated when water is re-formed, can 
cover the full energy needs of the eukaryotic cell. 
The generation and distribution of energy from 
melanin are surprisingly accurate and fast 
processes. They happen the same way since the 
beginning of time. And the changes we observed 
in the biomass reflect the accuracy of the energy 
generated by the melanin, as the continuous 
changes or metabolism that organic molecules 
have continuously in the human body, also occur 
with an astonishing accuracy. 
The impairment of generation and 
distribution of energy  
The biological processes of the body are very 
sensitive to changes in the available energy. and 
sooner or later they are reflected in the 
functioning of the organism. When the accuracy 
in the generation and distribution of energy is 
perturbed, for instance, by cold; then our body 
goes in imbalance and clinical manifestations 
should ensue. 
It is relatively unpredictable the type of signs or 
symptoms that could be presented when the 
balance between mass and energy occur in 
human body. 
In the case of the macula of the eye, the delicate 
anatomy of this highly specialized zone is 
deformed by the presence of blood, 
inflammation, neovascularization, atrophy, etc. 
But finally, the patient notices the distortion of 
images. which is progressive according to how 
the anatomy of retina is more and more altered. 
We call it age-related macular degeneration 
(AMD) because it is more frequent from the 60s. 
It is the leading cause of visual impairment in 
elderly persons in industrialized countries. The 
term degeneration can be defined as 
“deterioration of a tissue or an organ in which its 
function is diminished, or its structure is 
impaired”, in other words: “A retrogressive 
pathologic change in cells or tissues in 
consequence of which their functions are often 
impaired or destroyed; sometimes reversible; 
necrosis results in the early stages”. 
In accordance with different sources of 
information, i.e. National Eye Institute of NIH, 
currently, no treatment exists for early AMD. The 
benefit of nutritional supplements will not restore 
vision already lost from intermediate AMD and 
perhaps help slow vision loss in people who 
already have late AMD. In the case of 
neovascular AMD, typically results in severe 
vision loss. And several treatments are 
discussed: intraocular injections, photodynamic 
therapy, and laser surgery. However, the 
panorama is bleak, as AMD remains as the 
leading cause of blindness in industrialized 
countries as it has been for the past 60 years or 
more. This indicates that the treatments 
currently available for AMD are not working, 
because the incidence and prevalence of this 
disease has not varied significantly.  
The good news 
As we understood and deepened the 
fundamental role of melanin in molecular 
biology, we could understand that the usual 
manifestations of AMD are basically an 
imbalance between mass and energy in the 
organism and that can manifest in the macula. 
That is why despite the exhaustive studies at 
both the macro and microscopic level, both 
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anatomical and histochemical; the 
pathophysiology of AMD has not been 
understood, and the adage is fulfilled that we 
cannot cure what we do not understand. 
There are some studies about energy 
disturbances in diseases such as heart failure 
and Alzheimer's disease, and even treatments 
have been attempted in human patients, but they 
have failed because researchers were 
considering energy as an important etiological 
factor, but they insisted Insist on including 
glucose and ATP in the theoretical schemes of 
energy metabolism.  
So, we developed some pharmacological 
strategies to try to restore the lost balance 
between mass and energy according our 
research, and the results exceeded our own 
expectations.  
Case studies: 
Patient 1) Female patient, M.G., in the eighth 
decade of Life, who presented a gradual loss of 
vision in the left eye. She was attended by other 
physicians, but the loss of vision advanced 
inexorably. When months later she presented 
the same symptoms in the contralateral eye and 
realizing the null usefulness of the available 
treatments; the patient decided to go with us. 
The ophthalmological examination showed data 
compatible with AMD of neovascular type 
(Figure 3). 
It was explained to the patient and relatives the 
type of treatment we started to offer and given 
the little or no effectiveness of the various 
treatments she had tried in the left eye, she 
decided to use them. 
Because it is not a propaganda article, only of 
information that we consider important to be 
known, we only mention the therapeutic results, 
which by the way are extraordinary (Figure 4).  
Case study 2) 
Female patient in the seventh of life, who has 
distortions in the vision of the left eye for a few 
months, which have been aggravated despite 
several treatments by ophthalmologists. When 
they proposed the application by intraocular 
injection of anti-VEGF antibodies, she decided 
to assist to our office. 
The ophthalmological examination performed at 
the first consultation showed compatible findings 
with subretinal neovascularization or 
neovascular AMD (Figure 5). The anatomic and 
visual improvement were substantive (Figure 6) 
 
 
Figure 3) Case study 1. The photograph shows the typical appearance of choroidal 
neovascularization that grows disorderly and abruptly, deforming the anatomy and 
physiology of the over-lying retinal tissues. 
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Figure 4) Case study 1. The patient was reviewed within 21 days of commencement of 
treatment. Since she walked into the office without Help, we realized things were going well. 
And so it was, the vision had improved 80%, and the ophthalmological examination showed 
an astonishing improvement in the anatomy of the macula.  
 
 
Figure 5) Case study 2: The appearance of the retina suggests that the current lesion (yellow 
arrow) had been preceded by previous imbalance events (blue arrows), one of the scarred, 
which is denoted by melanin presence in the area. The photo corresponds to the first test 
before the beginning of the treatment. 
 
 
Figure 6) Case study 2: The patient went to review three months after being continuously 
using our treatment. The improvement is manifested by the notable decrease in exudates 
(yellow arrow) and by the decrease of the retinal folds (blue arrows) caused by the edema of 
the tissues.  
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Case study 3: 
Female patient in the seventh decade of life, who 
consulted us via email from France, because a 
family member who lives in our city told him from 
our research. The patient had been diagnosed 
as AMD in intermediate stages by an 
ophthalmologist. Her retinal studies of the right 
eye (Figure 7) showed changes compatible with 
the diagnosis of AMD, so we advise you to use 
our treatment. 
Periodically, the patient wrote to us and told us 
that it began to improve, to the degree that the 
Ophthalmologist told her that it had been a 
miracle. Figure 8 clearly shows the 
disappearance of the cystic spaces inside the 
retina, characteristic of AMD. The difference 
between the two studies is one year. (Figure 8) 
 
 
Figure 7) Case study 3: Typical appearance of abnormal accumulation of fluorescein in the 
Macular area (arrows) which is normally dark. The study was performed prior to the 
commencement of treatment. 
 
 
Figure 8) Case study 3: IN the upper part is observed the study of optical coherence 
tomography practiced in October 2009, where we appreciate a cystic lesion (yellow arrow) 
that is characteristic of AMD. In the lower part, we observe the study of optical coherence 
tomography dated September 22, 2010, which shows that the cystic lesion disappeared, and 
the contour of the macular region is now within normal limits. 
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Case study 4)  
Female Patient, in the sixth decade of life, with 
long-evolving axial myopia, who begins with 
metamorphopsias that gradually were taking the 
form of a dense central scotoma. At the 
ophthalmological examination, a hemorrhage 
below macular region is seen (Figure 9). At 8 
weeks of treatment, sub-macular hemorrhage 
has decreased significantly. (Figure 10). At 
twelve weeks of initiation the treatment the blood 
disappeared in its entirety with scarce scar 
tissue. (Figure 11). 
 
 
Figure 9) Case study 4. IN The first examination, a remarkable blood extravasation is seen 
(arrows), covering the entire macular region. 
 
 
Figure 10) Case study 4: At 8 weeks after the treatment started, the blood has disappeared 
for the most part, with little or no residual reaction. 
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Figure 11) Case study 4: After twelve weeks of treatment, the result is very encouraging, 
because the blood already disappeared in its entirety or null fibrosis reaction. 
 
Case study 5) 
A 45-year-old female Patient, who develops a 
hemorrhage in the macular region consequent a 
bronchopneumonia. (Figure 12, Upper, left) 
After one week of treatment, the blood has 
reabsorbed largely (Figure 12, up, right). At the 
third week of treatment, the blood disappeared 
completely, without apparent tissue damage, 
except for a depigmentation zone. (Figure 12, 
down, right and left) 
 
 
Figure 12) Case study 5: In the upper part, on the left, there is a hemorrhage that covers the 
fovea centralis. At the top, to the right; Blood that has been reabsorbed remarkably with 
treatment. At the bottom, it is appreciated that, at three weeks after the initiation of treatment, 
the blood has disappeared completely without retinal alterations, except for a thin line of 
hypopigmentation. 
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Case study 6) 
Female Patient in the eighth decade of Life, with 
intermediate myopia from the youth, who 
presents fluctuations of vision in right eye of 
three weeks of evolution, which have been 
worsening. 
A major hemorrhage in sub-macular region is 
observed in ophthalmological examination. 
(Figure 13). At the sixth month of treatment, the 
hemorrhage has completely disappeared, and 
the vision has recovered substantially, as the 
patient refers that he could no longer cook, and 
now he can do it, as well as wander without help. 
(Figure 14) 
 
 
Figure 13) Photograph of the right eye retina taken in the first exam. A major sub-macular 
hemorrhage Is seen.  
 
 
Figure 14) Case study 6:  The Blood has completely reabsorbed, the whitish striations 
observed, have been seen before. The Foveola centralis, or is observed in good condition 
with the blue filter (Up, right) 
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The Six cases of macular degeneration that we 
present here are demonstrative, because they 
are not the only ones or the best, in fact are the 
cases of macular degeneration that we can show 
with a couple of photographs.  
AMD, the Alzheimer s´ disease of the eye? 
The cross-sectional association between low 
cognitive function and early AMD has been 
carefully documented [13]. It can be sustained, 
beyond reasonable doubt, that AMD and 
cognitive impairment may share similar complex 
pathogenesis and risk factors.  
Neurodegenerative diseases, the leading cause 
of morbidity and disability, are gaining increased 
attention as they impose a considerable 
socioeconomic impact, due in part to the ageing 
community. Neuronal damage is the 
pathological hallmark of Alzheimer’s disease 
(AD) and Age-related Macular Degeneration 
(AMD) and various neurodegenerative illnesses 
such as Parkinson’s diseases, amyotrophic 
lateral sclerosis, Huntington’s disease, 
spinocerebellar ataxia and multiple sclerosis. 
A common feature of neurodegenerative 
diseases is chronic activation of innate immune 
cells within the CNS, and in other diseases such 
as multiple sclerosis (MS),  New concepts about 
immune environment of CNS are emerging from 
the study of the inﬂux of peripheral immune cells 
across the blood–brain barrier (BBB), 
identiﬁcation of lymphatic drainage, as well as by 
detailed studies on immune cell trafﬁcking in the 
choroid plexus (CP). [14] 
There is indirect evidence that free radicals and 
excited-state species play a key role in both 
normal biological function and in the 
pathogenesis o human diseases. Generation of 
activated species by inflammatory cells mediate 
important components of the inflammatory 
response. The evidence for a role for 
electronically activated species in human 
diseases has long been prevalent. However, 
free radicals and other activated species are so 
difficult to measure under biological conditions, 
so the evidence for their role for electronically in 
biological process is normally indirect and 
circumstantial. [15] 
Thereby AD and AMD present with increased 
production of activated species or with increased 
levels of radical- generating substances. The 
pathogenic pathways leading to 
neurodegeneration in AD include accumulation 
of aberrant or misfolded proteins, ubiquitin-
proteasome system dysfunction, excitotoxic 
reactions, oxidative and nitrosative stress; 
mitochondrial injury, synaptic failure, altered 
metal homeostasis dysfunction of axonal and 
dendritic transport, and misoperation of 
chaperones [16]. Such a widespread failure is 
only possible when the problem is energy. 
So far, the major obstacle in managing the 
disease and thereby the designing of rational 
therapeutic targets is the incomplete 
understanding of the pathogenesis of the 
disease. Several hypotheses have been 
proposed to explain the pathogenesis of AD, 
including theories involving amyloid deposition, 
tau phosphorylation; oxidative stress; metal ion 
dysregulation, and chronic inflammation.  
Unfortunately, no single one of these theories is 
enough to explain the spectrum of abnormalities 
found in the disease. However, the generation 
and distribution of energy that comes from 
melanin through dissociation and re-formation of 
water in form of molecular hydrogen (H2) and 
high energy electrons (e-) seems to be a good 
candidate as fundamental initiator of the 
pathological cascade.  
The cases of Alzheimer’s which we present and 
have been treated with the Therapeutic strategy 
based on Neuromelanin as a source of energy 
are a significant test of the importance of the 
light, visible and invisible, as a main energy 
source of the CNS. 
Case study 7: 
Female Patient in the eighth decade of life, who 
begins with forgetfulness, fears, sudden 
changes in mood, and progressive incapacitate 
of taking care of herself. During the previous 4 
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years she had received treatments of various 
types without results. 
Case study 8) 
Female Patient in the seventh decade of life, 
who a few years after having retired from a social 
security institution in Mexico, began with 
increasing memory problems, which were added 
intense depression, aggression, excessive 
fears, and growing disorientation. Despite 
different treatments used in the previous 3 years, 
the general state of the patient continued to 
deteriorate, so that her relatives decided to go to 
our Study center. 
 
 
Figure 15) Case study 7: Photograph taken during the first exam, the expression is typical of 
Alzheimer's disease (anger, deep sadness, fear, aggression). 
 
 
Figure 16) Case study 7: The close-up shows in greater detail the usual characteristics of 
facial expression of Alzheimer’s patients. The photograph was taken at the time of the first 
exam 
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Figure 17) Case study 7: The photograph was taken two years after we started treatment with 
drugs developed by us. The improvement is substantive. 
 
 
Figure 18) Case study 8: The patient's facial expression reveals fear, sadness, fear, anxiety. 
Note the position of the family's hands (left). The photograph was taken during the first exam. 
 
 
Figure 19) Case study 8: The position of the hands of the relative (left) now looks more 
relaxed, after three months of treatment, because the changes she has noticed in the sick 
are egregious. The photograph was taken three months after we started our treatment. 
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Case study 9) 
Female Patient at the beginning of the eighth 
decade of Life, who presented mild problems of 
behavior and memory that have get worse. 
Relatives have tried various treatments without 
much result, so they come to us for an 
evaluation. 
Case study 10) 
Female Patient in the eighth decade of life, with 
progressive dementia of several years of 
evolution, which has been worsening despite the 
care of relatives. When the patient attended the 
first consultation, no longer communicating in 
any way, was in a wheelchair and required the 
use of diapers. She suspended  the medication 
she was using so far and started to  use our 
treatments.  
 
 
Figure 29) Case study 9: In the photograph taken during the first examination, the facies that 
characterize the dementia type Alzheimer, the most common one, are seen. Note the 
aggressiveness, the fear, the deep depression.  
 
 
Figure 30) Case study 9: After three months of treatment initiation, changes in facial 
expression are substantive. 
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Figure 31) Case study 10: The picture shows the appearance of the patient who could be 
seen in the first exam. The physical and mental condition were deplorable. 
 
 
Figure 32) Case study 10: After six months of treatment, noticeable changes are seen in the 
expression of the sick, who already ate better, socialized more, was able to ask for water or 
food.  
 
Case study 11) 
Female Patient in the ninth decade of life, with 
DX of AD since 2007, was examined for the first 
time in our study Center in 2010. 
Case study 12) 
Female Patient in the seventh of life, who 
presents alterations of behavior that have been 
get worse, because he does not want to leave 
his room, leaves the stove on, does not want to 
bathe, his behavior is aggressive. 
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Figure 33) Case study 11: The patient's depression was so intense that she did not raise her 
head during the entire consultation. Photograph taken in the first exam. 
 
 
Figure 34) Case study 11: This photograph was taken six months after our treatment started. 
The improvement is surprising.  
 
 
Figure 35) Case study 11: The patient's gaze at six months of initiation treatment is very 
significant. 
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Figure 36) Case study 12: Photo taken during the first exam, notice the lack of personal care. 
 
 
Figure 37) Case study 12: Three months after the initiation of treatment, the patient shows a 
noticeable improvement. Facial expression is different, and her personal care has improved 
ostensibly. 
 
Case study 13) 
Male Patient in the seventh life, who starts with 
behavior problems that have gradually 
worsened, to the extent of getting lost in the 
street, can no longer work.  
Case study 14) 
Female Patient in the ninth decade of Life, who 
presents invalidity of several years, requires 
wheelchair, marked depression, loss of memory 
moderate to marked at times, and uses 14 
medicines of different types. Denies Diabetes 
mellitus. 
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Figure 38) Case study 13: The appearance of the sick in the first exam. There Is apathy, loss 
of interest; depression. 
 
 
Figure 38) Case study 13: 4 months later, and despite not having followed the treatment 
properly, there was improvement, which can be glimpsed in this photograph, because there 
is a significant improvement in his mood.  
 
 
Figure 39 ) Case study 14: Photograph at first examination.  
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Figure 40) Case study 14: After one month of treatment, facial expression is different. 
 
Case study 15) 
Female Patient in the eighth of life who began 
with forgetfulness without apparent importance 
but have been increasing to constitute an 
obstacle to their daily life, four years of evolution.  
Case study 16: 
Female Patient in the eighth decade of Life, 
which has changed behavior for 5 years, which 
have gradually worsened. 
 
 
Figure 41) case study 15: The appearance of the patient in the first examination, reflects 
fatigue, depression. 
 
 
Figure 41) case study 15: After three months of treatment, the facial expression has changed, 
Since the 15 days of treatment, the relatives refer that noticed positive changes in the patient, 
which have been increasing. 
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Figure 42) Case study 16: Depression is a constant finding in patients with progressive 
cognitive problems, as reflected in the clinical photograph of the patient at the time of the 
first exam. 
 
 
Figure 43) case study 17: At two months of treatment the changes are already perceptible in 
facial expression. 
 
Case study 17:  
Female Patient in the sixth decade of life, who 
has mild cognitive alterations that have 
progressed and begin to obstruct daily life. Five 
years of evolution. 
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Conclusion: 
The cases of study presented in this article and 
whit a growing number each day,  are a proof no 
only significant even substantive because they 
demonstrate beyond the reasonable doubt the 
role of hydrogen as a carrier of energy in the 
human body, possibility that had already been 
proposed by Prof Szent Gyoögyi, in 1961 [17]; 
Even he said that if there is a constant hydrogen 
source it would be easy to explain biology; but 
not knowing at that time the unsuspected 
bioenergetic role of melanin; the professor 
Szent-Györgyi argued that glucose was the 
packaging by which nature transported the 
hydrogen from the outside into the human 
body[18]. 
The energy metabolism of the glucose-based 
organism resulted in false news that appeared 
and lasted in the textbooks. 
The cases we present are not the only or the 
best, but the ones we can publish succinctly and 
that show beyond reasonable doubt, that we 
must discard the mistaken idea of an energy 
metabolism based on the oxidation of glucose. 
Glucose as source of energy It Is a collective 
mistake that already has too many decades and 
every day that passes causes more and more 
damage, as well as unnecessary suffering. 
The purpose of this article is, above all; make a 
call to collective consciousness so that each of 
us does what is necessary for the new biology, 
which implies a new era in medical practice; get 
to the general public as soon as possible and 
can be used massively for the benefit of the sick 
and society. 
The challenge is formidable, for it is ideally that 
the new knowledge about that the human body 
can directly use sunlight, like plants as well; It 
should appear in the shortest possible time in 
textbooks from elementary degrees of education 
to the most advanced, washout glucose as 
source of energy. 
Likewise, all the actors in the different social 
structures will have to do their part to favor the 
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profound change that is required to modify the 
course of the society towards a preventive and 
corrective medicine very different to the current 
one but that is more human and efficient. 
We talk about politicians, educational 
authorities, health authorities, tax authorities; 
Universities, research centers, professionals; 
associations, academies; Pharmaceutical 
laboratories of all sizes, in short; of each and 
every one of the elements that make up society 
to do their part to propitiate the rapid 
establishment of a new era in biology and 
medicine that will be, without a doubt; a huge 
collective benefit. 
It Is better to recognize as soon as possible that 
universities and research centers were wrong to 
continue to perpetuate the long-lasting mistakes 
even more. 
The population ingests a large number of drugs 
that then urinate, and is an important part of the 
growing pollution of the environment that we can 
effectively prevent; we know now that the 
patients do not require so many medicines, it is 
only essential that there is a balance between 
mass and energy, and the body will repair itself 
as it has done millions of years, millions of times. 
To stop producing and consuming so many 
medicines will be a breath of fresh air for both 
society and the environment. Medicine has 
become more and more complex and 
increasingly expensive, now we have a great 
opportunity to correct the course. 
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